NUWE Nuwellis, Inc.

Nasdaq nuwellis.com


$ 3.41 $ 0.05 (1.46 %)    

Tuesday, 14-Oct-2025 15:59:53 EDT
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 3.47
$ 3.45
$ 3.30 x 50
$ 3.87 x 1
-- - --
$ 3.09 - $ 175.98
36,394
na
nm
$ 1.22
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-11-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 03-11-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-03-2023 12-31-2022 10-K
12 11-08-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-03-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-25-2021 12-31-2020 10-K
20 11-12-2020 09-30-2020 10-Q
21 08-05-2020 06-30-2020 10-Q
22 05-14-2020 03-31-2020 10-Q
23 03-05-2020 12-31-2019 10-K
24 11-08-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 02-21-2019 12-31-2018 10-K
28 11-07-2018 09-30-2018 10-Q
29 08-09-2018 06-30-2018 10-Q
30 05-10-2018 03-31-2018 10-Q
31 03-22-2018 12-31-2017 10-K
32 11-02-2017 09-30-2017 10-Q
33 08-10-2017 06-30-2017 10-Q
34 05-12-2017 03-31-2017 10-Q
35 03-08-2017 12-31-2016 10-K
36 11-14-2016 09-30-2016 10-Q
37 08-11-2016 06-30-2016 10-Q
38 05-05-2016 03-31-2016 10-Q
39 03-15-2016 12-31-2015 10-K
40 11-05-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 robert-b-scott-resigns-as-cfo-of-nuwellis-john-l-erb-appointed-interim-cfo

https://www.sec.gov/Archives/edgar/data/1506492/000114036125037713/ef20056785_8k.htm

 nuwellis-announces-findings-from-ultra-peds-registry-study-examining-real-world-use-of-aquadex-system-in-children-with-aki-fluid-overload-or-congenital-kidney-failure

ULTRA-Peds Registry, the largest multi-center dataset of its kind, shows Aquadex therapy was well-tolerated in critically ill c...

 nuwellis-secures-us-patent-for-hemolysis-sensor-technology-in-blood-filtration-systems-supporting-pediatric-device-vivian-and-platform-innovation

Nuwellis, Inc., a fluid management company, today announced that the United States Patent and Trademark Office has issued U.S. ...

 nuwellis-signs-loi-to-acquire-rendiatech-advancing-renal-monitoring-capabilities-beyond-ultrafiltration-deal-expected-to-close-in-q4-2025

Proposed acquisition supports strategy to drive technology expansion of fluid management offering to include continuous renal h...

 nuwellis-announces-first-patients-have-been-successfully-treated-with-aquadex-ultrafiltration-therapy-in-a-hospital-based-outpatient-setting

 Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company dedicated to transforming fluid management, today announced that th...

 nuwellis-shareholders-approve-warrant-exercise-share-increase-from-100m-to-200m-and-reverse-split-at-a-ratio-between-1-for-5-to-1-for-70-to-boost-financial-flexibility

Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company focused on fluid management, today announced that stockholders appro...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION